Head-to-Head Comparison
OpenEvidence vs UpToDate: Which Is Better for Physicians?
OpenEvidence: AI Research Assistant for Evidence-Based Clinical Decisions UpToDate: Clinical Reference, Interactive Tools, and Expert AI
Updated
Direct Answer
Source: Clinical AI Report, 2026
Key takeaways
- OpenEvidence is free for verified clinicians, asks for a US NPI at sign-up and, under its September 17, 2026 terms, is not available in the EU, EEA or UK.
- UpToDate costs $579 a year for one US clinician, with Expert AI included in US personal plans, according to its store in October 2026; students, residents and fellows pay $219 a year.
- UpToDate grades its recommendations with the GRADE system and lets readers inspect the references behind them, with content from 7,400+ physician authors.
- OpenEvidence has no drug dosing tools or differential diagnosis generator, and a December 2025 preprint reported 41% accuracy on complex subspecialty scenarios.
Feature Comparison
| Feature | OpenEvidence | UpToDate |
|---|---|---|
| Rating | OpenEvidence: Good | UpToDate: Good |
| Category | OpenEvidence: AI Medical Research Assistant | UpToDate: Clinical Reference & Decision Support |
| Pricing | OpenEvidence: Free (Ad-Supported) | UpToDate: Subscription pricing varies by location, role, and package |
| Founded | OpenEvidence: 2022 | UpToDate: 1992 |
| Headquarters | OpenEvidence: Miami, FL | UpToDate: Waltham, MA |
| Evidence Citations | OpenEvidence: Yes | UpToDate: Yes |
| AI Differential Diagnosis | OpenEvidence: No | UpToDate: No |
| Drug Database | OpenEvidence: No | UpToDate: No |
| Drug Interaction Checker | OpenEvidence: No | UpToDate: No |
| Medical Calculators | OpenEvidence: Yes | UpToDate: Yes |
| Natural Language Search | OpenEvidence: Yes | UpToDate: No |
| Document & Image Upload | OpenEvidence: No | UpToDate: No |
| EHR Integration | OpenEvidence: Yes | UpToDate: Yes |
| Mobile App | OpenEvidence: Yes | UpToDate: Yes |
| Built-in Dialer | OpenEvidence: Yes | UpToDate: No |
| AI Clinical Scribe | OpenEvidence: No | UpToDate: No |
| CME Credits | OpenEvidence: No | UpToDate: Yes |
| Multi-Language | OpenEvidence: Yes | UpToDate: No |
Strengths & Limitations
OpenEvidence
Strengths
- +Useful for generalist clinical questions — fast, cited answers for everyday practice
- +Widely adopted clinical AI in the US (757K+ physicians)
- +Free for all verified physicians
- +Broadest content partnership network: NEJM, JAMA (all 11 specialty journals), NCCN, ACC, AAFP, ACEP, ADA, AAOS, 300+ journals
- +Native iOS and Android apps with Home Screen widgets
- +Quick Consult and Deep Consult modes for different clinical needs
- +Built-in dialer for calling patients, pharmacies, and colleagues
- +Well-funded with strong investor backing ($12B valuation, $100M annual revenue)
Limitations
- –No differential diagnosis generation or drug dosing tools
- –Ad-supported revenue model (pharmaceutical/healthcare advertising)
- –EHR integration is early-stage (Sutter Health/Epic announced February 2026)
- –Preprint by Jagarapu et al. (2025) reported 41% accuracy on complex subspecialty scenarios
- –Clinical depth narrower than platforms with drug databases and medical calculators
UpToDate
Strengths
- +Read expert-authored topics and inspect the references behind recommendations
- +Use Expert AI to ask conversational questions when enabled for your account
- +Use interactive Pathways and Lab Interpretation when included in your license
- +Access content on mobile, with a separate entitlement for offline downloads
- +Accrue eligible CME/CE/CPD through supported professional subscriptions
Limitations
- –Expert AI and package features vary by subscription and region
- –A local store quote is needed to compare your actual subscription cost
- –Offline content access does not establish offline Expert AI access
- –EHR linking, chart access, and workflow automation are separate capabilities to verify
- –No new clinical accuracy or timed usability test was performed for this refresh
Key Statistics
OpenEvidence
UpToDate
Citable Summaries
OpenEvidence
OpenEvidence has an editorial score of 73/100 (3.7/5), calculated from Clinical AI Report's published criteria weights. It ranks #2 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
UpToDate
UpToDate combines an expert-authored reference library with Expert AI for eligible accounts; evaluate the actual subscription, source-review workflow, and regional availability before choosing a package.
Source: Clinical AI Report, May 2026
Our Assessment
In our 2026 evaluation, OpenEvidence (ranked #2, 3.7 stars) outperforms UpToDate (ranked #3, 3.6 stars) in overall physician satisfaction and editorial scoring. OpenEvidence is best suited for a useful tool for physicians who need fast, cited answers to clinical questions grounded in peer-reviewed literature. Relevant for primary care, internal medicine, and emergency medicine. Free and backed by a broad content partnership network (NEJM, JAMA, NCCN, ACC, AAFP, ACEP). Meanwhile, UpToDate is a stronger choice for clinicians and organizations that want an expert-authored reference library with traceable recommendations, plus Expert AI and workflow tools where their subscription supports them Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.